Navigation Links
Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs
Date:3/17/2008

CANTON, Mass., March 17 /PRNewswire/ - Organogenesis, Inc., announced today that Damien Bates, MD, PhD, FRACS (Plast.), has joined the company as vice president of medical affairs.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080317/AQM095)

Dr. Bates combines more than twelve years of surgical practice with solid regenerative medicine industry experience. He has practiced in orthopedic, dermatologic, vascular, oncologic and general surgery, infectious diseases and intensive care, both in the U.S. and Australia. An accomplished board-certified plastic and reconstructive surgeon, Dr. Bates will serve an important and multi-faceted role within Organogenesis. In addition to leading the company's clinical study department, Dr. Bates will strengthen Organogenesis' links to the surgical community. He will also impact patient lives by collaborating with Organogenesis research and development teams to guide new product development from lab science through to approved products.

"This is an exciting time for Organogenesis, and Damien's appointment serves to solidify our executive team," said Geoff MacKay, chief executive officer of Organogenesis. "Damien's wealth of experience in tissue engineering, stem cell biology and surgical wound healing is a great fit for Organogenesis as we grow our company, as well as our product pipeline."

Organogenesis is in the midst of a large expansion, both in employees as well as facilities, and also recently acquired the electro-spinning platform technology company NanoMatrix. The company is currently developing a number of new products, and recently launched the first-ever direct-to-consumer (DTC) educational campaign for a living cell therapy (its flagship product Apligraf(R)).

Prior to joining Organogenesis, Dr. Bates served as attending plastic and reconstructive surgeon for the University of Colorado, The Children's a
'/>"/>

SOURCE Organogenesis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. STERIS Corporation Names Michael J. Tokich Chief Financial Officer
2. Take Care Health Systems Names Butler, Shine, Stern & Partners as First Marketing Agency of Record
3. Study names 5 factors of social ills in energy, mining and logging communities
4. Cardinal Health Names Michael C. Kaufmann to Lead Pharmaceutical Segment
5. Nellson Nutraceutical Names New Directors and Interim Chief Executive Officer
6. EaglePicher Medical Power Names Joseph Marotta Vice President of Sales and Marketing
7. Independent Survey Names CyberKnife(R) System Most Widely Used Extracranial Radiosurgery Technology
8. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
9. Numira Biosciences Names New Board Member
10. Senior Lifestyle Corporation Names John Cobb as President and CEO
11. Women Health Care Executives Names Genomic Health President Kimberly Popovits as Woman of the Year

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... SHENZHEN, China, Nov. 9 /PRNewswire-Asia-FirstC...E: MR ), a leading developer, manufacturer and,ma...ay its selected unaudited,financial results for th...,2009. , , Highlights for Operations as of Se...enues were $151.1 million, an increase of, 3...
(Date:11/9/2009)...House action backs President Obama,s promise to no... example ,, Bishops still concerned for poor,...ewswire/ -- Cardinal Francis George of Chicago, pr...c Bishops, lauded the November 7 decision of the U...th care reform money from paying for elective abor...
(Date:11/9/2009)... Studying Genetic Variance Acros...ts of Genes , (Vocus) Nov...estries can be extraordinarily valuable when analy...ti-center genetics study that scanned the genome...r regional differences, Drs. Chao Tian and Michael...
(Date:11/9/2009)... implanted with new cells regained sexual function...lthDay News) -- Researchers were able to restore s...growing new penile tissue in the lab and implantin...lication is a ways off, researchers say the techni... dysfunction in men. , "We were able to show th...
(Date:11/9/2009)... Course, to be Offered in April ...olkit , Cambridge, MA (Vo...ysicians for Human Rights (PHR) first inspected a ...tan , he realized he would need a team of experts ...ing the site properly was a key first step in secu...
Breaking Medicine News(10 mins):Health News:Mindray Announces Third Quarter 2009 Financial Results 2Health News:Mindray Announces Third Quarter 2009 Financial Results 3Health News:Mindray Announces Third Quarter 2009 Financial Results 4Health News:Mindray Announces Third Quarter 2009 Financial Results 5Health News:Mindray Announces Third Quarter 2009 Financial Results 6Health News:Mindray Announces Third Quarter 2009 Financial Results 7Health News:Mindray Announces Third Quarter 2009 Financial Results 8Health News:Mindray Announces Third Quarter 2009 Financial Results 9Health News:Mindray Announces Third Quarter 2009 Financial Results 10Health News:Mindray Announces Third Quarter 2009 Financial Results 11Health News:Mindray Announces Third Quarter 2009 Financial Results 12Health News:Mindray Announces Third Quarter 2009 Financial Results 13Health News:Mindray Announces Third Quarter 2009 Financial Results 14Health News:Mindray Announces Third Quarter 2009 Financial Results 15Health News:Mindray Announces Third Quarter 2009 Financial Results 16Health News:Mindray Announces Third Quarter 2009 Financial Results 17Health News:Mindray Announces Third Quarter 2009 Financial Results 18Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 3Health News:News from the November/December Issue of Molecular Medicine 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4
...y 6 Carriage Services, Inc. (NYSE: CSV ) today ...h 31, 2009. Highlights from continuing operations...st quarter of 2008 were as follows: , , First Qu... 2008 2009 Change, ...
...Tenn., May 6 TeamHealth Inc.,s parent company, Te...sults for the first quarter of 2009. , , Net re...less provision") in the first quarter of 2009 incr... $319.0 million from $305.5 million in the same pe...
... stents should discuss the use of these meds with ...SDAY, May 6 (HealthDay News) -- Anyone who takes t...tent in a coronary artery-opening procedure should...cid reflux medications such as Nexium, Prevacid an...
...ns emphasize need for improved mental health servi... The Regence Foundation announced today it awarded...es in Idaho, Oregon, Utah and Washington. Five of ...ted transformation grant program. , , "Encouragin...
...f those hospitalized in U.S. is 15, CDC says , ...the large majority of U.S. cases continue to be mi...disease appear to be atypically young, health offi..., U.S. Centers for Disease Control and Prevention ...
...ELEY, Calif., May 6 The following was released ...new report from the National Institute for Occu...in Las Vegas casinos are exposed to dangerous leve... , In 2005, blackjack dealers working in three Las...
Other Medicine News:Health News:Carriage Services Announces First Quarter 2009 Results 2Health News:Carriage Services Announces First Quarter 2009 Results 3Health News:Carriage Services Announces First Quarter 2009 Results 4Health News:Carriage Services Announces First Quarter 2009 Results 5Health News:Carriage Services Announces First Quarter 2009 Results 6Health News:Carriage Services Announces First Quarter 2009 Results 7Health News:Carriage Services Announces First Quarter 2009 Results 8Health News:Carriage Services Announces First Quarter 2009 Results 9Health News:Carriage Services Announces First Quarter 2009 Results 10Health News:Carriage Services Announces First Quarter 2009 Results 11Health News:Carriage Services Announces First Quarter 2009 Results 12Health News:Carriage Services Announces First Quarter 2009 Results 13Health News:Carriage Services Announces First Quarter 2009 Results 14Health News:Carriage Services Announces First Quarter 2009 Results 15Health News:Team Finance LLC Announces First Quarter 2009 Results 2Health News:Team Finance LLC Announces First Quarter 2009 Results 3Health News:Team Finance LLC Announces First Quarter 2009 Results 4Health News:Team Finance LLC Announces First Quarter 2009 Results 5Health News:Team Finance LLC Announces First Quarter 2009 Results 6Health News:Team Finance LLC Announces First Quarter 2009 Results 7Health News:Team Finance LLC Announces First Quarter 2009 Results 8Health News:Plavix, Heartburn Drugs May Be Risky Combination 2Health News:Plavix, Heartburn Drugs May Be Risky Combination 3Health News:Regence Foundation Grants $390,000 to Improve Health Care Safety Net 2Health News:Regence Foundation Grants $390,000 to Improve Health Care Safety Net 3Health News:Younger Age of Severe Swine Flu Cases Worries Experts 2Health News:Younger Age of Severe Swine Flu Cases Worries Experts 3Health News:Younger Age of Severe Swine Flu Cases Worries Experts 4Health News:Younger Age of Severe Swine Flu Cases Worries Experts 5Health News:Younger Age of Severe Swine Flu Cases Worries Experts 6Health News:Younger Age of Severe Swine Flu Cases Worries Experts 7Health News:Younger Age of Severe Swine Flu Cases Worries Experts 8Health News:Younger Age of Severe Swine Flu Cases Worries Experts 9Health News:Younger Age of Severe Swine Flu Cases Worries Experts 10Health News:Younger Age of Severe Swine Flu Cases Worries Experts 11
(Date:11/9/2009)...PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc...ults from the Company,s Bepreve(TM) (bepotastine b... studies. These results were presented in poster ...n College of Allergy, Asthma & Immunology (ACA...ation titled, "Treatment of Ocular Itching with Be...
(Date:11/9/2009)...., Nov. 9 Thomson Reuters today ... CareFocus, a leading clinical surveillance soluti...ents in real-time and respond immediately to impro...ment. ,, This upgrade is available to current C...CareFocus 2.0 contains several powerful enhancemen...
(Date:11/9/2009)...ov. 9 Arcadia Resources,...novative consumer health care services under the A... Goldsmith to its Board of Directors. Goldsmith w...n from the Board. ,, (Photo: http://www.ne...Goldsmith is the Daniel Paul Professor of Governme...
Breaking Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Arcadia Resources Names Stephen Goldsmith to Board of Directors 2Arcadia Resources Names Stephen Goldsmith to Board of Directors 3NATB Announces Partnership With Ronald McDonald House Charities 28R 29 53932 1NATB Announces Partnership With Ronald McDonald House Charities 28R 29 53932 2NATB Announces Partnership With Ronald McDonald House Charities 28R 29 53932 3Mother 26 Daughter Celebrate Victory Over Meth 53930 1Mother 26 Daughter Celebrate Victory Over Meth 53930 2American Oriental Bioengineering Reports Second Quarter 2009 Financial Results 13442 1American Oriental Bioengineering Reports Second Quarter 2009 Financial Results 13442 2American Oriental Bioengineering Reports Second Quarter 2009 Financial Results 13442 3American Oriental Bioengineering Reports Second Quarter 2009 Financial Results 13442 4American Oriental Bioengineering Reports Second Quarter 2009 Financial Results 13442 5American Oriental Bioengineering Reports Second Quarter 2009 Financial Results 13442 6American Oriental Bioengineering Reports Second Quarter 2009 Financial Results 13442 7American Oriental Bioengineering Reports Second Quarter 2009 Financial Results 13442 8
...l 17 The SurgiLance safety lancet,an industry-lea...rpose, has,been selected for inclusion in an HIV k... Bundi International Diagnostics. Long established...cets are now part of a major,testing initiative de...,continent., A critical component of the fight ag...
...onstrate Predictable, Extended Exposure with Susta..., CHICAGO, April 17 Data from the first pivotal ...nvestigational compound to treat,Restless Legs Syn... the,symptoms of moderate-to-severe primary RLS co...d when administered once-daily for 12 weeks., Dat...
Other Medicine Technology:SurgiLance Safety Lancet Part of Major HIV Testing Initiative in Sub-Saharan Africa 2Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 2Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 3Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 4Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 5Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 6
Creatine Kinase Reagent
Creatine Kinase-MB (CK-MB)
Magnesium Liquid Reagent
Glucose Oxidase Reagent Set (Phenol Free)
Medicine Products: